
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evraz Plc | LSE:EVR | London | Ordinary Share | GB00B71N6K86 | ORD USD0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 80.89 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
EVRAZ plc (EVR) EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.USD750,000,000 5.375 per cent. notes due 2023 08-Dec-2022 / 11:17 MSK Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITATION MEMORANDUM.
EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.USD750,000,000 5.375 per cent. notes due 2023
London, 8 December 2022 - on 15 November 2022, EVRAZ plc (the "Issuer") announced a consent solicitation in relation to the outstanding U.S.USD750,000,000 5.375 per cent. notes due 2023 issued by the Issuer (Regulation S Notes: Common Code 153391572 / ISIN XS1533915721; Rule 144A Notes: Common Code 111731110 / ISIN US30050AAG85 / CUSIP 30050AAG8) (the "Notes") on the terms and subject to the conditions set forth in the consent solicitation memorandum dated 15 November 2022 (the "Consent Solicitation Memorandum"). Capitalised terms used, but not defined herein, shall have the meanings given to them in the Consent Solicitation Memorandum.
The Appointment Extraordinary Resolution and the Amendment Extraordinary Resolution were each passed at the Meeting of Noteholders held on 7 December 2022. Each of the Appointment and the Amendments will become effective upon execution of (i) the Deed of Appointment and (ii) the Supplemental Trust Deed, which will be separately notified to investors by the Issuer.
The Issuer extends its gratitude for the support and cooperation demonstrated by investors, which has been reflected in the successful results of the Consent Solicitation.
Questions and requests for assistance in connection with the Consent Solicitation should be directed to the Information and Tabulation Agent:
Limited liability company "Legal Capital Investor Services"
Address: 10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia
Email: evraz@lcpis.ru
Phone: +7 495 122 05 17
Website: www.lcpis.ru
###
For further information:
Investor Relations
+7 495 232 1370
ir@evraz.com
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00B71N6K86, XS1533915721, XS1843443273, Category Code: MSCH TIDM: EVR LEI Code: 5493005B7DAN39RXLK23 OAM Categories: 2.2. Inside information Sequence No.: 207086 EQS News ID: 1507855 End of Announcement EQS News Service =------------------------------------------------------------------------------------
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1507855&application_name=news
(END) Dow Jones Newswires
December 08, 2022 03:17 ET (08:17 GMT)
1 Year Evraz Chart |
1 Month Evraz Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions